Top Biotech Investors
Leading venture capital firms and institutional investors in biotech.
Showing3,071 investors tracked
| # | Investor Name | Portfolio Companies | Focus Areas |
|---|---|---|---|
| 1 | Public ShareholdersMoberg Pharma, PharmaMar, NGM Biopharmaceuticals +66 more | 69 | Oncology, Cardiovascular |
| 2 | Not Publicly DisclosedAlchemy, Cambridge Epigenetix, Deep MedChem +64 more | 67 | Oncology, Neuroscience |
| 3 | Information not widely publicizedSynthioLabs, Exin Therapeutics, Delineate +60 more | 63 | Oncology, Immunology |
| 4 | Hillhouse CapitalGenocury Biotech, VivaVision Biotech, Tenacia Biotechnology +52 more | 55 | Oncology, Immunology |
| 5 | ARCH Venture PartnersBlank Bio, Scholar Rock, CellThera AI +47 more | 50 | Oncology, Immunology |
| 6 | Sequoia Capital ChinaGenocury Biotech, VivaVision Biotech, Allorion Therapeutics +42 more | 45 | Oncology, Immunology |
| 7 | National Institutes of Health (NIH)Astrocyte Pharmaceuticals, CinderBio, Chrysalis BioTherapeutics +39 more | 42 | Oncology, Neurodegenerative Diseases |
| 8 | OrbiMedLomond Therapeutics, Edge Medical, Zion Pharma +38 more | 41 | Oncology, Immunology |
| 9 | Atlas VentureConvexia, Eluminex Biosciences, Auron Therapeutics +36 more | 39 | Oncology, Immunology |
| 10 | Qiming Venture PartnersGenocury Biotech, Zencore Biologics, VivaVision Biotech +36 more | 39 | Oncology, Immunology |
| 11 | Flagship PioneeringAnto Biosciences, Alltrna, Ring Therapeutics +27 more | 30 | Oncology, Immunology |
| 12 | Lilly Asia VenturesTenacia Biotechnology, InventisBio, Impact Therapeutics +22 more | 25 | Oncology, Immunology |
| 13 | Private InvestorsA2A Pharma, GlycoMira, GenZum Life Sciences +22 more | 25 | Oncology, Metabolic Disorders |
| 14 | ForbionNewAmsterdam Pharma, Kynexis, Pheon Therapeutics +21 more | 24 | Oncology, Infectious Disease |
| 15 | Public MarketsInventisBio, Junshi Biosciences, JW Therapeutics +21 more | 24 | Oncology, Infectious Disease |
| 16 | Khosla VenturesClear Labs, NextVivo, NewLimit +17 more | 20 | Oncology, Cardiology |
| 17 | RA Capital ManagementLusaris Therapeutics, Advanced Cellular Dynamics, Nature's Toolbox +16 more | 19 | Oncology, Immunology |
| 18 | Angel investorsSDIP Innovations, MyoGene Bio, NERx Biosciences +15 more | 18 | Oncology, Autoimmune Diseases |
| 19 | GVBlank Bio, Volastra Therapeutics, Rome Therapeutics +15 more | 18 | Oncology, Immunology |
| 20 | Sofinnova PartnersSitryx Therapeutics, Forward Therapeutics, F-star Therapeutics +15 more | 18 | Oncology, Immunology |
| 21 | Versant VenturesConvexia, Belharra Therapeutics, Vicinitas Therapeutics +15 more | 18 | Oncology, Immunology |
| 22 | TF CapitalImpact Therapeutics, ImmuneOnco Biopharma, Evive Biotech +14 more | 17 | Oncology, Immunology |
| 23 | F-Prime CapitalAllorion Therapeutics, ARTBIO, CHARM Therapeutics +13 more | 16 | Oncology, Immunology |
| 24 | Novo HoldingsRibon Therapeutics, Vita Therapeutics, Zencore Biologics +12 more | 15 | Oncology, Immunology |
| 25 | Polaris PartnersScholar Rock, Volastra Therapeutics, Pretzel Therapeutics +12 more | 15 | Oncology, Immunology |
| 26 | Boyu CapitalEdge Medical, Ocumension Therapeutics, Lepu Biopharma +11 more | 14 | Oncology, Immunology |
| 27 | BpifranceCarmat, Carbios SAS, Inotrem +11 more | 14 | Oncology, Inflammatory Diseases |
| 28 | TemasekCirCode Biomed, Viva Biotech, Westlake Genetech +11 more | 14 | Oncology, Infectious Disease |
| 29 | The Column GroupScoop, NGM Biopharmaceuticals, Quanta Therapeutics +11 more | 14 | Oncology, Ophthalmology |
| 30 | Y CombinatorGeneral Proximity, Zeon Systems, Uh-Oh Labs +11 more | 14 | Oncology, Immunology |
| 31 | Andreessen HorowitzBlank Bio, CellThera AI, Rome Therapeutics +10 more | 13 | Oncology, Autoimmune Diseases |
| 32 | GL VenturesCureGene, Escugen, Codone Biotechnology +10 more | 13 | Oncology, Genetics & Genomics |
| 33 | Novartis Venture FundIaso Bio, F-star Therapeutics, Granite Bio +9 more | 12 | Oncology, Immunology |
| 34 | OrbiMed AsiaEvive Biotech, Conjustar, Biomics Biopharma +9 more | 12 | Oncology, Immunology |
| 35 | Sinovation VenturesEvive Biotech, Conjustar, Delova Biotech +9 more | 12 | Oncology, Immunology |
| 36 | Third Rock VenturesARTBIO, Perimeter Systems, Inc., Merida Biosciences +9 more | 12 | Oncology, Immunology |
| 37 | CBC GroupCytoCares, 3D Medicines, MLAB Biosciences +8 more | 11 | Oncology, Immunology |
| 38 | Deerfield ManagementRibon Therapeutics, Bitterroot Bio, Imris, Deerfield Imaging +8 more | 11 | Oncology, Immunology |
| 39 | M VenturesF-star Therapeutics, Asceneuron, PictorLabs +8 more | 11 | Oncology, Immunology |
| 40 | Public market investorsAkari Therapeutics, Unity Biotechnology, NextCure +8 more | 11 | Immunology, Oncology |
| 41 | UndisclosedModulo Bio, BioHeal AI, Holobiome +8 more | 11 | Oncology, Metabolic Disorders |
| 42 | Cormorant Asset ManagementAccurEdit Therapeutics, Scoop, Numab Therapeutics +7 more | 10 | Oncology, Immunology |
| 43 | SV Health InvestorsSitryx Therapeutics, EyeBio, SpectraWAVE +7 more | 10 | Oncology, Immunology |
| 44 | Information not publicly availableZiJian Biotechnology, Visirna Therapeutics, SmartNuclide Biopharma +6 more | 9 | Oncology, Immunology |
| 45 | Sanofi VenturesArialys Therapeutics, Character Biosciences, Lifordi Immunotherapeutics +6 more | 9 | Immunology, Ophthalmology |
| 46 | 5AM VenturesRadionetics Oncology, Lifordi Immunotherapeutics, PIC Therapeutics +5 more | 8 | Oncology, Solid Tumors |
| 47 | Access BiotechnologyAuron Therapeutics, Arialys Therapeutics, Delphia Therapeutics +5 more | 8 | Immunology, Oncology |
| 48 | Alexandria Venture InvestmentsIgGenix, Kallyope, PIC Therapeutics +5 more | 8 | Immunology, Metabolic |
| 49 | Bill & Melinda Gates FoundationNanite, Sherlock Biosciences, Claremont BioSolutions +5 more | 8 | Oncology, Infectious Disease |
| 50 | Fidelity Management & Research CompanyNewBiologix, Syngene International, ElevateBio +5 more | 8 | Oncology, Immunology |